الإحصائيات الأساسية
| CIK | 1676163 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to SS Innovations International, Inc.
SEC Filings (Chronological Order)
توفر هذه الصفحة قائمة كاملة ومرتبة ترتيبًا زمنيًا لتصريحات هيئة الأوراق المالية والبورصات، باستثناء تصريحات الملكية التي نقدمها في مكان آخر.
| August 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 7, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 7, 2025 |
Exhibit 99.1 SS Innovations Reports Second Quarter 2025 Financial Results Record Quarterly Revenue of $10.0 Million Driven by Higher SSi Mantra 3 Unit Sales Gross Profit More than Tripled, Driven by Gross Margin Expansion and Revenue Growth Fort Lauderdale, FL – August 7, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgica |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-42615 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of regis |
|
| July 28, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 23, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| July 22, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 22, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| July 22, 2025 |
Exhibit 99.1 SS Innovations Announces Completion of World’s First Intercontinental Robotic Cardiac Telesurgery Performed by Dr. Sudhir Srivastava utilizing the Company’s SSi Mantra 3 surgical robotic system Remotely conducted from IRCAD in Strasbourg, France at an unprecedented distance of more than 4,000 miles to the operating room at SAIMS in Indore, India Fort Lauderdale, FL – July 22, 2025 – S |
|
| July 15, 2025 |
Exhibit 99.1 SS Innovations Surpasses Milestone of 100 Installations of the SSi Mantra Surgical Robotic System Continuing strong procedure growth, including an upsurge in telesurgeries Fort Lauderdale, FL – July 15, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surger |
|
| July 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 15, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| July 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 10, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| July 10, 2025 |
Exhibit 99.1 SS Innovations Announces Completion of World’s First Robotic Telesurgery for Weight Loss with the Company’s SSi Mantra 3 Surgical Robotic System ● Led by Dr. Mohit Bhandari, a pioneer in bariatric surgery and President of the Institute of Research Against Digestive Cancer (IRCAD) India, the surgery was remotely performed at a distance of 560 miles and executed on-site at Mohak Bariatr |
|
| June 16, 2025 |
Exhibit 99.1 SS Innovations Announces Successful Completion of First Robotic Cardiac Surgery in the Western Hemisphere Utilizing the Company’s SSi Mantra 3 Surgical Robotic System Surgery performed by Dr. Juan Zuniga at Interhospital in Guayaquil, Ecuador Fort Lauderdale, FL – June 16, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of inno |
|
| June 16, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 16, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| June 3, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 3, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| June 3, 2025 |
Exhibit 99.1 We Build Advanced, Affordable and Accessible Surgical Robotic Solutions SS Innovations International, Inc. Company Presentation June 2025 Nasdaq: SSII Forward - Looking Statements This Presentation contains forward - looking statements within the meaning of Section 27 A of the Securities Act of 1933 , as amended and Section 21 E of the Securities Exchange Act of 1934 , as amended . Th |
|
| June 2, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 2, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 001-42615 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| June 2, 2025 |
SS Innovations to Ring the Nasdaq Opening Bell on Tuesday, June 3, 2025 Exhibit 99.1 SS Innovations to Ring the Nasdaq Opening Bell on Tuesday, June 3, 2025 Fort Lauderdale, FL – June 2, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company will ring the op |
|
| May 27, 2025 |
Exhibit 99.1 SS Innovations Surpasses Milestone of 4,000 Robotic Surgeries Successfully Performed with the SSi Mantra Surgical Robotic System Fort Lauderdale, FL – May 27, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global popu |
|
| May 27, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 27, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| May 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 21, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| May 14, 2025 |
Exhibit 99.1 SS Innovations Reports First Quarter 2025 Financial Results Record Quarterly Revenue of $5.1 Million Driven by Higher SSi Mantra 3 Unit Sales On Track for July 2025 De Novo Application to the FDA for SSi Mantra 3 Fort Lauderdale, FL – May 14, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technol |
|
| May 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of regi |
|
| May 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 14, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| May 8, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 8, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| May 8, 2025 |
Exhibit 99.1 SS Innovations to Submit De Novo Application to the FDA for the SSi Mantra 3 Surgical Robotic System for Multiple Indications All Clinical Data Validated by Leading Third-Party CRO for Safety, Feasibility and Efficacy Fort Lauderdale, FL – May 8, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic tec |
|
| May 5, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 5, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| May 5, 2025 |
Exhibit 99.1 SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends Fort Lauderdale, FL – May 5, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, toda |
|
| May 2, 2025 |
Consulting Agreement between SS Innovations International, Inc. and Trogon Consulting Exhibit 10.1 TROGON CONSULTING GCX Thomas Manor | Richmond Road | Bangalore 560025 April 1, 2025 Sudhir Srivastava Innovations Pvt Ltd. (SS Innovations Group) 404-405, 3rd Floor, iLabs Info Technology Centre Udyog Vihar Phase III Gurugram (Haryana) India 122016 Attention: Mr. Anup Sethi Subject: Contractual arrangement for CFO services Dear Mr Sethi, Thank you for discussing with us the requiremen |
|
| May 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 30, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| May 2, 2025 |
SS Innovations Announces Chief Financial Officer Transition Exhibit 99.1 SS Innovations Announces Chief Financial Officer Transition Fort Lauderdale, FL – May 2, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Arvind Palaniappan as the C |
|
| April 25, 2025 |
As filed with the Securities and Exchange Commission on April 25, 2025 As filed with the Securities and Exchange Commission on April 25, 2025 Registration No. |
|
| April 25, 2025 |
Exhibit 107 Calculation of Filing Fee Tables S-8 (Form Type) SS Innovations International, Inc. |
|
| April 24, 2025 |
Fort Lauderdale, FL – April 24, 2025 Exhibit 99.1 Fort Lauderdale, FL – April 24, 2025 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company’s common stock has been approved for listing on The Nasdaq Capital Market® (“Nasdaq”). Tr |
|
| April 24, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 SS Innovations International, Inc. (Exact name of registrant as specified in its charter) Florida 47-3478854 (State of incorporation or organization) (I.R.S. Employer Identification No.) 1600 SE 15 |
|
| April 24, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 24, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| April 15, 2025 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name Jurisdiction of Organization Percentage of Ownership Direct Subsidiaries CardioVentures Inc. Delaware 100% Avra IP Holdings, Inc. Delaware 100% SSI IP Holdings, Inc. Delaware 100% Indirect Subsidiaries Otto Pvt. Ltd. Bahamas 100% owned by CardioVentures Inc. Sudhir Srivastava Innovations Pvt. Ltd. India 91.60% owned directly by Otto Pvt. Ltd.; 7.15% own |
|
| April 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or Other Jurisdiction of (I.R.S. |
|
| April 15, 2025 |
Nominating and Corporate Governance Committee Charter(4) Exhibit 99.3 NOMINATING AND CORPORATE GOVERNANCE COMMITTEE CHARTER OF SS INNOVATIONS INTERNATIONAL, INC. Effective as of January 1, 2025 I. PURPOSE The Nominating and Corporate Governance Committee (the “Nominating Committee”) is appointed by the board of directors (the “Board”) of SS Innovations International, Inc. (the “Company”): (a) to assist the Board by identifying qualified candidates for d |
|
| April 15, 2025 |
Exhibit 14.2 CERTIFICATION SS INNOVATIONS INTERNATIONAL, INC. Insider Trading Compliance Program And Insider Trading Policy Acknowledgement Page I have received, read, understand and agree to comply with the SS Innovations International, Inc. Insider Trading Compliance Program including the Insider Trading Policy, which is attached thereto as Appendix I to the accompanying Memorandum from our Chai |
|
| April 15, 2025 |
Exhibit 99.1 AUDIT COMMITTEE CHARTER OF SS INNOVATIONS INTERNATIONAL, INC. Effective as of January 1, 2025 I. PURPOSE The Audit Committee shall provide assistance to the Board of Directors (the “Board”) of SS Innovations International, Inc. (the “Company”) in fulfilling the Board’s responsibility to the Company’s shareholders relating to the Company’s accounting and financial reporting practices, |
|
| April 15, 2025 |
Compensation Committee Charter(4) Exhibit 99.2 COMPENSATION COMMITTEE CHARTER OF SS INNOVATIONS INTERNATIONAL, INC. Effective as of January 1, 2025 I. PURPOSE The purpose of the Compensation Committee of the board of directors (the “Board”) of SS Innovations International, Inc. (the “Company”) is: 1. To discharge the responsibilities of the Board relating to compensation of the Company’s directors and executive officers; 2. To ass |
|
| April 1, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 to Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 SS INNOVATIONS INT |
|
| March 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 31, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| March 31, 2025 |
OMB APPROVAL UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB Number: 3235-0058 Expires: April 30, 2025 Estimated average burden hours per response. 2.50 FORM 12b-25 SEC FILE NUMBER 000-56608 CUSIP NUMBER NOTIFICATION OF LATE FILING 05453U203 (Check one): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: December 31, |
|
| March 31, 2025 |
Exhibit 99.1 SS Innovations Achieves Significant Milestones in 2024 The Company’s award winning SSi Mantra surgical robotic system has completed over 3,500 surgeries and is clinically validated to perform more than 100 different types of surgical procedures The Company Continues to Build a Strong Foundation for Future Growth FORT LAUDERDALE, FL, March 31, 2025 - SS Innovations International, Inc. |
|
| March 27, 2025 |
EX-99.1 2 ea023586101ex99-1ssinno.htm PRESS RELEASE, DATED MARCH 27, 2025 Exhibit 99.1 SS Innovations International, Inc. Achieves Another Milestone by Successfully Performing Over 2,000 km North-to-South Robotic Cardiac Telesurgery with its SSi Mantra 3 Surgical Robotic System ● The SSI Mantra 3 Surgical Robotic System enabled a seamless connection from SS Innovations headquarters in Gurugram, In |
|
| March 27, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 27, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| March 13, 2025 |
SS Innovations Unveils India’s First Mobile Tele-Surgical Unit at SMRSC 2025 Exhibit 99.1 SS Innovations Unveils India’s First Mobile Tele-Surgical Unit at SMRSC 2025 Fort Lauderdale, FL - March 13, 2025 - SS Innovations International, Inc. (OTC:SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced that it unveiled its |
|
| March 13, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 13, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| March 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 to Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 SS INNOVATIONS INTERNAT |
|
| March 7, 2025 |
SS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025 Exhibit 99.1 SS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025 Fort Lauderdale, Fla., March 7, 2025: SS Innovations International, Inc. (OTC:SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced the la |
|
| March 7, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 7, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| February 19, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 to Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the three months ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 SS INNOVATIONS INTERNATION |
|
| February 13, 2025 |
EX-1 2 ea023072701ex1ssinnova.htm JOINT FILING AGREEMENT Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities and Exchange Act of 1934, as amended, the undersigned agree that the Statement on Schedule 13G to which this exhibit is attached is filed on behalf of each of them. Each of them is individually eligible to use Schedule 13G to which this exhibit is |
|
| February 12, 2025 |
Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) promulgated under the Securities and Exchange Act of 1934, as amended, the undersigned agree that the Statement on Schedule 13G to which this exhibit is attached is filed on behalf of each of them. |
|
| January 24, 2025 |
Unregistered Sales of Equity Securities, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 4, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| January 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 to Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 SS INNOVATIONS INT |
|
| January 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 to Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 SS INNOVATIONS INTERNAT |
|
| January 13, 2025 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 13, 2025 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| January 13, 2025 |
Exhibit 99.1 SS Innovations International Performs World’s First Robotic Cardiac Telesurgeries with its SSi Mantra 3 ● A Robotic-Assisted Internal Mammary Artery Harvesting Telesurgery procedure was successfully completed in 58 minutes. ● The world’s first Robotic Beating Heart Totally Endoscopic Coronary Artery Bypass (TECAB) Telesurgery was performed with a latency of only 40 milliseconds (less |
|
| December 20, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 2 to Form 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or |
|
| December 11, 2024 |
Exhibit 99.1 SS Innovations Announces Completion of BDO Audit Process and Issues Update on Plans for NASDAQ Uplisting Fort Lauderdale, FL., December 11, 2024 - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, toda |
|
| December 11, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 11, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| December 10, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 10, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| December 10, 2024 |
India’s First CDSCO Certified Robotic System for Telesurgery: SSI Mantra Leads the Way Exhibit 99.1 India’s First CDSCO Certified Robotic System for Telesurgery: SSI Mantra Leads the Way ● SS Innovations becomes the first and only company in India to receive regulatory approval for Telesurgery and Teleproctoring capabilities of a surgical robotic system, its SSi Mantra, marking a significant achievement in surgical robotics ● SS Innovations reinforces India’s position as a hub for t |
|
| December 9, 2024 |
December 9, 2024 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications & Services 100 F Street, N. |
|
| December 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 to Form 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or |
|
| December 2, 2024 |
SSII / SS Innovations International, Inc. / Pai Ranjan R - SCHEDULE 13G Passive Investment SC 13G 1 ea0223304-13gpaissinnova.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* SS Innovations International, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 05453U203 (CUSIP Number) November 25, 2024 (Date of Event Which Requires Filing of this Statement) Check the |
|
| November 27, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 26, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| November 27, 2024 |
SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia Exhibit 99.1 SS Innovations Marks a Milestone with First Robotic Cardiac Surgery in Indonesia ● SS Innovations marks a milestone with the successful completion of Indonesia’s first robotic cardiac surgery using its SSi Mantra Surgical Robotic System. ● Dr. Sudhir Srivastava, Founder, Chairman, and CEO of SS Innovations successfully performed the first Beating Heart Totally Endoscopic Coronary Arte |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of |
|
| September 30, 2024 |
Exhibit 99.1 SS Innovations Welcomes Mr. Tim Adams, Leader in the Health Care Industry, to Board Tim Adams to serve as Independent Board Director FORT LAUDERDALE, FL, September 30, 2024) - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessib |
|
| September 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 30, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| September 23, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 23, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| September 23, 2024 |
Exhibit 99.1 Revolutionizing Surgery: SS Innovations International Inc. Celebrates 2,000 Procedures with its SSi Mantra Surgical Robotic System Fort Lauderdale, FL., September 23 2024 - SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to |
|
| September 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 11, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| September 11, 2024 |
Exhibit 99.1 SS Innovations Conducts Interactive Meeting with the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) and Updates its Expected FDA Approval Timeline Fort Lauderdale, FL., September 11, 2024 - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to m |
|
| September 10, 2024 |
Exhibit 99.1 SS Innovations Welcomes “Father of Surgical Robotics” Dr. Fredric Moll to Board Dr. Moll, founder of Intuitive Surgical, to serve as Vice Chairman. FORT LAUDERDALE, FL, September 10, 2024) - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordab |
|
| September 10, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 10, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| September 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of regis |
|
| September 3, 2024 |
Exhibit 99.1 SS Innovations International, Inc. Announces First Mantra Surgical Robotic System Sale in South America SS Innovations receives Regulatory Approval for Clinical Use in Ecuador SS Innovations Partners with Medical Device Firm Ingemedica S.A. for Distribution in Ecuador The first SSi Mantra Surgical Robotic System to be installed at Interhospital, Guayaquil City, Ecuador Fort Lauderdale |
|
| September 3, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 3, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| August 30, 2024 |
SS Innovations Issues Update on Status of Audit Process and Trading Market for Common Stock Exhibit 99.1 SS Innovations Issues Update on Status of Audit Process and Trading Market for Common Stock Fort Lauderdale, FL., August 30 2024 - SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today issued an updat |
|
| August 30, 2024 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 30, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 20, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 14, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 000-56608 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| July 31, 2024 |
Exhibit 99.1 SSI Mantra 3 An Advanced Surgical Robotic © 2024 SS Innovations International, Inc. | Confidential and Proprietary | All Rights Reserved 1 Sudhir Prem Srivastava, MD Founder, Chairman and CEO SS Innovations Group Companies No Offering of Securities No offer is made by this Investor Presentation (this “Presentation”) to invest in SS Innovations International, Inc. (the “Company”) or to |
|
| July 31, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 23, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| July 19, 2024 |
Exhibit 99.1 Meet The Latest Innovation In Robotic Surgery: The SSi Mantra-3 New Disruptive System With The Potential To Bring Life-Saving Technology To Every Corner Of The Planet To Be Unveiled in New York For An Exclusive Demonstration Fort Lauderdale, FL., July 18, 2024 - SS Innovations International, Inc. (the Company” or “SS Innovations”) (OTC: SSII), developer of innovative surgical robotic |
|
| July 19, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 18, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| July 9, 2024 |
SSi Mantra Expands Global Footprint: Nepal's First Surgical Robot Set to Transform Healthcare Sector Exhibit 99.1 SSi Mantra Expands Global Footprint: Nepal's First Surgical Robot Set to Transform Healthcare Sector ● Baidya & Banskota (B&B) Hospital Installs Nepal's First Surgical Robotic System, India made SSi Mantra ● SSi Mantra integrates cutting edge advancements in robotic surgery, offering surgeons unparalleled precision and control for improved patient outcomes ● SS Innovations helps reinf |
|
| July 9, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 9, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| June 17, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 17, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| June 17, 2024 |
Exhibit 99.1 SS Innovations Designated “Outstanding Company” Finalist for Surgical Robotics Industry Awards 2024 Annual awards celebrate the best of the surgical robotics industry. Fort Lauderdale, FL., June 17, 2024 – Globe Newswire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making worl |
|
| June 11, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 11, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| June 11, 2024 |
SS Innovations’ SSi Mantra Surgical Robotic System Approved for Use in Indonesia Exhibit 99.1 SS Innovations’ SSi Mantra Surgical Robotic System Approved for Use in Indonesia Fort Lauderdale, FL., June 11, 2024 – Globe Newswire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable and accessible to a global population, today announc |
|
| May 31, 2024 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 29, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| May 31, 2024 |
Exhibit 99.1 SS Innovations Engages BDO as its new Auditor SS Innovations believes that the selection of BDO will facilitate uplisting of its common stock to a National Securities Exchange and reflects the Company’s commitment to transparent financial and accounting practices and regulatory compliance FORT LAUDERDALE, Fla., May 31, 2024 (GLOBE NEWSWIRE) – SS Innovations International, Inc. (the “C |
|
| May 21, 2024 |
Exhibit 99.1 SS Innovations’ SSi Mantra Surgical Robotic System Used to Perform 100 Cardiac Surgeries, Signaling Market Expansion ● The SSi Mantra surgical robotic system has surpassed the 100 surgery milestone for robotic cardiac surgery ● SS Innovations maintains the world’s only comprehensive robotic cardiac surgery program ● SSi Mantra used in more than 1000 procedures globally ● Company antic |
|
| May 21, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 21, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of regi |
|
| May 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 10, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| April 29, 2024 |
Exhibit 99.1 SS Innovations Achieves Pediatric Milestone with First Infant Pyeloplasty Using SSi Mantra Surgical Robotic System Company’s flagship SSi Mantra surgical device has now been used in more than 1000 procedures Fort Lauderdale, FL., April 29, 2024 - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies |
|
| April 29, 2024 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 29, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| April 22, 2024 |
Exhibit 99.1 SS Innovations International Announces Q1 2024 Company Updates Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system Fort Lauderdale, FL., April 22, 2024 - News Direct - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making world class robotic surger |
|
| April 22, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 22, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| March 22, 2024 |
Exhibit 21.1 SUBSIDIARIES OF REGISTRANT Name Jurisdiction of Organization Percentage of Ownership Direct Subsidiaries CardioVentures Inc. Delaware 100% Avra IP Holdings, Inc. Delaware 100% SSI IP Holdings, Inc. Delaware 100% Indirect Subsidiaries Otto Pvt. Ltd. Bahamas 100% owned by CardioVentures Inc. Sudhir Srivastava Innovations Pvt. Ltd. India 92.62% owned directly by Otto Pvt. Ltd.; 6.11% own |
|
| March 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or Other Jurisdiction of (I.R.S. |
|
| March 12, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): March 12, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| March 12, 2024 |
Exhibit 99.1 SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement The first Mitral Valve Replacement using the Made in India SSi Mantra Surgical Robotic System was successfully performed at the Narayana Institute of Cardiac Sciences in Bengaluru, India. Fort Lauderdale, FL., March 12, 2024 - News Direct - SS Innovations International, Inc. (the “Company” or “ |
|
| February 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 13, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| February 14, 2024 |
As filed with the Securities and Exchange Commission on February 14, 2024. As filed with the Securities and Exchange Commission on February 14, 2024. Registration No. 333- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 3841 47-3478854 (State or other jurisdiction of incorporation or organization) (Pr |
|
| February 14, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) SS Innovations International, Inc. |
|
| February 14, 2024 |
SSII / SS Innovations International, Inc. / MOLL FREDERIC H - SC 13G Passive Investment SC 13G 1 d786743dsc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) * SS Innovations International, Inc. (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 05453U203 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statem |
|
| February 9, 2024 |
SSII / SS Innovations International, Inc. / SRIVASTAVA SUDHIR - SCHEDULE 13G Passive Investment SC 13G 1 ea193005-13gsrivastssinnova.htm SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.)* SS Innovations International, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 05453U203 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check t |
|
| February 1, 2024 |
Exhibit 99.1 SS Innovations Demonstrates Groundbreaking Telesurgery Platform at Company’s First Multi-Specialty Robotic Surgical Conference Remote coronary artery suturing performed on animal model via SS Innovations’ telesurgery platform SMRSC 2024 welcomed global medical experts and innovators to explore the future of robotic surgery Fort Lauderdale, FL., February 1, 2024 - News Direct – SS Inno |
|
| February 1, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): February 1, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| January 26, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 26, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| January 26, 2024 |
Exhibit 99.1 SS Innovations Announces Filing of Pre-Submission Application to the Center for Devices and Radiological Health (CDRH) of the United States Food and Drug Administration Fort Lauderdale, FL., January 26, 2024 - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery a |
|
| January 25, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 25, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| January 25, 2024 |
Exhibit 99.1 SS Innovations Partners with India’s Leading Medical Equipment Supplier, Medikabazaar Collaboration to facilitate sales of the SSi Mantra Surgical Robotic System to hospitals and medical facilities across India Fort Lauderdale, FL., January 25, 2024 - News Direct - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical ro |
|
| January 8, 2024 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): January 8, 2024 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| January 8, 2024 |
Exhibit 99.1 SS Innovations Achieves Significant Milestones in 2023 -Company’s award winning SSi Mantra surgical robotic system has completed over 550 surgeries and is clinically validated to perform more than 40 different types of surgical procedures- -Company Builds Strong Foundation for Future Growth- FORT LAUDERDALE, FL, January 8, 2024 - SS Innovations International, Inc. (the “Company” or “S |
|
| December 26, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 26, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| December 26, 2023 |
Exhibit 99.1 SS Innovations Announces Strategic Partnership with Surgical Lab for Distribution in Africa Pan African Medical Device Distributor Surgical Lab to place the SSi Mantra Surgical Robotic System in Healthcare Facilities across the African Continent Surgical Lab has Begun Registration of SSi Mantra in 27 African countries Fort Lauderdale, FL., December 26, 2023 - News Direct - SS Innovati |
|
| December 4, 2023 |
Exhibit 99.1 © S U D H I R S R I V A S T A V A I N N O V A T I O N S P V T . L T D . | C O N F I D E N T I A L I N F O R M A T I O N 1 SS INNOVATIONS PRODUCT PRESENTATION SUDHIR SRIVASTAVA INNOVATIONS PVT. LTD. - CONFIDENTIAL DISCLAIMERS 2 © S U D H I R S R I V A S T A V A I N N O V A T I O N S P V T . L T D . | C O N F I D E N T I A L I N F O R M A T I O N No Offering of Securities No offer is ma |
|
| December 4, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 4, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| November 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 27, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| November 27, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 27, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission F |
|
| November 27, 2023 |
Exhibit 99.1 SS Innovations International SSi Mantra Robotic Surgical System Crosses 500 Successful Procedure Milestone Company Founder and Chairman, Dr. Sudhir P. Srivastava performed complex heart surgery, while simultaneously, Dr. Sudhir K. Rawal, Medical Director for Rajiv Gandhi Cancer Institute, performed complex Urology Oncology surgery, marking 500 surgery milestone using the SSi Mantra Su |
|
| November 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 000-56608 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of |
|
| November 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 SS Innovations International, Inc. (Exact name of registrant as specified in its charter) Florida 47-3478854 (State of incorporation or organization) (I.R.S. Employer Identification No.) 1600 SE 15 |
|
| October 30, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): October 30, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| October 30, 2023 |
Exhibit 99.1 SS Innovations Appoints Dr. Sonia Shokeen as Head of Quality and Regulatory Affairs Dr. Shokeen brings over 15 years of medical device experience, including time spent at Johnson & Johnson Fort Lauderdale, FL., October 30, 2023 - News Direct - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies ded |
|
| October 16, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 12, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| October 16, 2023 |
Exhibit 99.1 SS Innovations Enters Licensing Agreement with Johns Hopkins University Company’s flagship SSi Mantra surgical system now installed at the university’s Baltimore campus Fort Lauderdale, FL., October 12, 2023 - News Direct - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making rob |
|
| August 17, 2023 |
Exhibit 99.1 SS Innovations Recognized on National News As India Celebrates Independence Day News channel, DD India, features SS Innovations’ work in the field of medical technology as an example of Indian excellence Fort Lauderdale, FL., August 17, 2023 - News Direct - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic te |
|
| August 17, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 17, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| August 8, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 8, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 8, 2023 |
Exhibit 99.1 SS Innovations and Dr. Frederic Moll to Deliver Keynote Presentation at the MoneyShow Investment Masters Symposium, Las Vegas Dr. Moll, known as the ‘father of robotic surgery’, is the founder of Intuitive Surgical and creator of the da Vinci surgical system. Fort Lauderdale, FL., August 8, 2023 - News Direct - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OT |
|
| August 8, 2023 |
Presentation, dated August 8, 2023 Exhibit 99.2 |
|
| August 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 30, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 7, 2023 |
Promissory Note made in favor of Sushruta Pvt. Ltd.(3) Exhibit 10.1 THIS CONVERTIBLE PROMISSORY NOTE (THE “NOTE”) AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE APPLICABLE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”) OR UNDER THE SECURITIES LAWS OF ANY STATE. THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TO THE DISTRIBUTION THEREOF. THIS NOTE AND THE SECURITIES ISSUABLE UPON |
|
| August 7, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of regi |
|
| August 7, 2023 |
Employment Agreement with Barry F. Cohen(3)+ Exhibit 10.2 EMPLOYMENT AGREEMENT THIS AGREEMENT, made effective April 14, 2023 (the “Effective Date”), between SS Innovations International Inc., a Florida corporation (hereinafter referred to as the “Company”), and Barry F. Cohen, residing at 1600 SE 15th Street, #512, Ft. Lauderdale, FL 33316, USA (hereinafter referred to as the “Employee”). WHEREAS, the Company wishes to engage the services an |
|
| August 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): August 2, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| August 2, 2023 |
Exhibit 99.1 SS Innovations Begins FDA and CE Regulatory Approval Processes for SSi Mantra Flagship Surgical Robotic Device Company retains Elexes, a regulatory and quality compliance firm with deep experience, to advance approval process FORT LAUDERDALE, FL / ACCESSWIRE /August 2, 2023 / SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC:SSII), a developer of innovative s |
|
| July 10, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): July 10, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| July 10, 2023 |
Exhibit 99.1 SS Innovations International, Inc. to Present at the Emerging Growth Conference on Wednesday July 12, 2023 SS Innovations invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference FORT LAUDERDALE, FL, July 10, 2023 - SS Innovations International, Inc. (the “Company” or “SS Innova |
|
| June 26, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A Amendment No. 1 to Form 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 14, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of I |
|
| June 6, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): June 6, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| June 6, 2023 |
Exhibit 99.1 SS Innovations International, Inc. © S S I N N O V A T I O N S I N T E R N A T I O N A L I N C . – C O N F I D E N T I A L A N D P R O P R I E T A R Y 1 Improving lives through innovation and care. JUNE 2023 DISCLAIMERS © S S I N N O V A T I O N S I N T E R N A T I O N A L I N C . – C O N F I D E N T I A L A N D P R O P R I E T A R Y 2 No Offering of Securities No offer is made by thi |
|
| June 6, 2023 |
Youâve Exceeded the SECâs Traffic Limit Exhibit 99.2 |
|
| May 30, 2023 |
Exhibit 99.1 SS Innovations International, Inc. Provides Business Update; Celebrates Achievement of Significant Milestones Company’s flagship SSi Mantra surgical robotic system utilized to perform successful complex cardiac, lung, head and neck surgeries SSi Mantra used in first pediatric urology surgery Robotic surgical system has now completed more than 200 surgeries; clinically validated in Ind |
|
| May 30, 2023 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 30, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of reg |
|
| May 15, 2023 |
Exhibit 99.1 SS Innovations International, Inc. (f/k/a Avra Medical Robotics, Inc.) Commences Trading under “SSII” Ticker Symbol and Provides Corporate Update SSII is a Developer of Innovative, Affordable and Accessible Surgical Robotic Technologies Ft Lauderdale, Florida – May 15, 2023 – SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative |
|
| May 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): May 15, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| April 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 14, 2023 SS INNOVATIONS INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| April 19, 2023 |
Exhibit 99.1 AVRA Medical Robotics Announces Closing of Merger with CardioVentures Announces Management Changes and Name Change to SS Innovations International, Inc. Fort Lauderdale, FL, April 19, 2023 - AVRA Medical Robotics, Inc. the “Company”) (OTC: AVMRD), a medical robotics software and artificial intelligence company announced that it has closed on its previously announced acquisition by mer |
|
| April 19, 2023 |
Employment Agreement with Dr, Sudhir Srivastava(2) Exhibit 10.1 Employment Agreement This Employment Agreement (Agreement) is entered into on November 11, 2019, by and between: Otto Pvt Ltd, a company incorporated in the Bahamas and having its registered office at Davis & Co, Parthenon Building, 17 West Street North, Nassau, Bahamas (hereinafter referred to as the “Company” which term or expression shall unless excluded by or repugnant to the subj |
|
| April 19, 2023 |
Employment Agreement with Dr. Vishwajyoti P. Srivastava(2)+ Exhibit 10.2 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is made on 01st Sept 2021 at Gurugram (India) between Otto Pvt Ltd. a company incorporated according to the laws of the Bahamas with registered office at Davis & Co. The Parthenon Building, No. 17, West Street North, Nassau, Bahamas (the “Company”), and Dr. Vishwajyoti Pascual Srivastava, residing at 28A Udyan Villa, Tri |
|
| April 19, 2023 |
Employment Agreement with Anup Sethi(2)+ Exhibit 10.3 EMPLOYMENT AGREEMENT This Employment Agreement (the “Agreement”) is made on 16th January 2023 at Gurgaon (India) between Otto Pvt Ltd. a company incorporated according to the laws of the Bahamas with registered office at Davis & Co. The Parthenon Building, No. 17, West Street North, Nassau, Bahamas (the “Company”), and Mr. Anup Kumar Sethi, residing at C-102, Dream Apartments, Plot-14 |
|
| April 19, 2023 |
Articles of Amendment to Amended and Restated Articles of Incorporation(2) Exhibit 3.1 2 3 4 5 6 7 |
|
| April 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): April 7, 2023 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Number) |
|
| April 14, 2023 |
Investment Agreement, dated April 7, 2023 Exhibit 10.1 INVESTMENT AGREEMENT THIS INVESTMENT AGREEMENT made and entered into as of April 7, 2023 (this “Investment Agreement”), by and among AVRA MEDICAL ROBOTICS, INC., a Florida corporation (“AVRA”), CARDIOVENTURES INC., a Delaware corporation (“CardioVentures”), DR. SUDHIR PREM SRIVASTAVA (“Dr. Srivastava”) and Dr. FREDERIC H. MOLL (“Dr. Moll”). AVRA, CardioVentures, Dr. Srivastava and Dr. |
|
| March 31, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or Other Jurisdiction of (I.R.S. Employe |
|
| December 2, 2022 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): December 1, 2022 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| December 2, 2022 |
AVRA Medical Robotics, Inc. (OTC: AVMR) Becomes Current in its SEC Filing Status EX-99.1 2 ea169561ex99-1avramedi.htm PRESS RELEASE DATED DECEMBER 1, 2022 Exhibit 99.1 AVRA Medical Robotics, Inc. (OTC: AVMR) Becomes Current in its SEC Filing Status For Immediate Release ORLANDO, FL - December 1, 2022 – AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR) today announced that as of November 30, 2022, it has filed all required periodic reports with the Securities an |
|
| November 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant |
|
| November 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant |
|
| November 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of regist |
|
| November 7, 2022 |
Merger Agreement, dated November 7, 2022 EX-2.1 2 ea168119ex2-1avramedical.htm MERGER AGREEMENT, DATED NOVEMBER 7, 2022 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among AVRA Medical Robotics, Inc., AVRA-SSI Merger Corporation, CardioVentures, Inc. and Dr. Sudhir Srivastava (solely with respect to Sections 3.4, 3.21, 4.4, 5.2, 7.1(a), 7.1(f), 7.2, 8.1 and 9.1) Dated as of November 7, 2022 AGREEMENT AND PLAN OF MERGER This AGREEMENT A |
|
| November 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported): November 7, 2022 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in its charter) Florida 333-216054 47-3478854 (State or Other Jurisdiction of Incorporation) (Commission File Numb |
|
| November 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant |
|
| November 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of regist |
|
| November 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or Other Jurisdiction of (I.R.S. Employe |
|
| November 4, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant |
|
| September 6, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or Other Jurisdiction of (I.R.S. Employe |
|
| August 8, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of regist |
|
| July 18, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant |
|
| June 30, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant |
|
| February 22, 2022 |
10-K 1 f10k2019avramedical.htm ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC (Exact name of registrant as specified in its charter) Florida 47-3478854 (S |
|
| September 14, 2021 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant 8-K 1 ea147397-8kavramedical.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 10, 2021 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in charter) Florida (State or other jurisdiction |
|
| September 14, 2021 |
Letter from D. Brooks and Associates CPAs, P.A. Exhibit 16.1 September 14, 2021 Office of the Chief Accountant Securities and Exchange Commission 460 Fifth Street N. W. Washington, DC 20549 Re: AVRA Medical Robotics, Inc. Commission File Number: 333-216054 Dear Sir/Madam: We have received a copy of, and are in agreement with, the statements being made by AVRA Medical Robotics, Inc., as they pertain to us, in Item 4.01 of its Form 8-K dated Sept |
|
| March 9, 2021 |
Exhibit 99.1 AVRA Medical Robotics, Inc. (OTCMKTS: AVMR) 2020 Year-End CEO Update Letter to Shareholders and the Investment Community For Immediate Release ORLANDO, FL - February 11, 2021 ? AVRA Medical Robotics, Inc. (?AVRA? or ?the Company?) (OTCMKTS: AVMR) today issued the following update letter by its CEO, Barry Cohen to shareholders and the investment community: Dear AVRA Shareholder, As 202 |
|
| March 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): March 1, 2020 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in charter) Florida (State or other jurisdiction of incorporation) 333-216054 47-3478854 (Commission F |
|
| January 29, 2021 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 26, 2021 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in charter) Florida (State or other jurisdiction of incorporation) 333-216054 47-3478854 (Commissio |
|
| January 29, 2021 |
AVRA Medical Robotics, Inc. (OTC: AVMR) New Auditors Exhibit 99.1 AVRA Medical Robotics, Inc. (OTC: AVMR) New Auditors For Immediate Release ORLANDO, FL - [January 28, 2021] – AVRA Medical Robotics, Inc. (“AVRA” or “the Company”) (OTC: AVMR) today issued the following update: On January 26, 2021, the board of directors of AVRA authorized the engagement of D. Brooks and Associates CPAs P.A. as the Company’s new auditors to replace the prior auditors |
|
| May 15, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number: 333-216054 NOTIFICATION OF LATE FILING (Check One) : ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-SAR ☐ Form N-CSR For Period Ended: December 31, 2019 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Fo |
|
| May 15, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2020 Avra Medical Robotics, Inc. (Exact name of registrant as specified in charter) Florida 333-216054 ?47-3478854? (State or other Jurisdiction of Incorporation) (Commission |
|
| March 30, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 30, 2020 Avra Medical Robotics, Inc. (Exact name of registrant as specified in charter) Florida 333-216054 47-3478854 (State or other Jurisdiction of Incorporation) (Commission |
|
| November 13, 2019 |
Quarterly Report - QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of regist |
|
| October 2, 2019 |
Unsecured Promissory Note dated December 31, 2018, made by the Company in favor of Barry F. Cohen(3) EX-10.15 7 fs12019ex10-15avramed.htm UNSECURED PROMISSORY NOTE DATED DECEMBER 31, 2018, MADE BY THE COMPANY IN FAVOR OF BARRY F. COHEN Exhibit 10.15 UNSECURED PROMISSORY NOTE $15,000 December 31, 2018 For value received, (the “Maker”), Avra Medical Robotics, Inc (OTCQB: AVMR) promises to pay to Barry F. Cohen (the “Holder”), the principal sum of Fifteen Thousand Dollars ($15,000). Maker will pay H |
|
| October 2, 2019 |
Collaborative Research and Development Agreement between the Company and Infinite Mind, LLC(3) Exhibit 10.10 COLLABORATIVE RESEARCH AND DEVELOPMENT AGREEMENT THIS COLLABORATIVE RESEARCH AND DEVELOPMENT AGREEMENT (the ?Agreement?) is entered into as of this 10th day of September (the ?Effective Date?), by and between INFINITE MIND LLC (?IM?), a Florida limited liability company having a place of business at 3259 Progress Drive, Suite 107, Orlando, Florida 32826 and AVRA MEDICAL ROBOTICS, INC |
|
| October 2, 2019 |
Service Agreement between the Company and Nicole Bergman-Fong Exhibit 10.14 PRIVATE & CONFIDENTIAL October 1st 2016 Ms. Nicole Bergman-Fong +1-917-375-5496 [email protected] Dear Nicole: This letter will set forth the principal terms of our offer to you to render advisory services to AVRA Medical Robotics, Inc. (?AVRA? or the ?Company?). Start Date: October 1, 2016. Position: Corporate Counsel reporting to AVRA?s Chief Executive Officer. Compensation: Dis |
|
| October 2, 2019 |
Unsecured Promissory Note dated May 29, 2019, made by the Company in favor of Barry F. Cohen(3) Exhibit 10.18 UNSECURED PROMISSORY NOTE $25,000 May 29, 2019 For value received, (the ?Maker?), Avra Medical Robotics, Inc (OTCQB: AVMR) promises to pay to Barry F. Cohen (the ?Holder?), the principal sum of Twenty Five Thousand Dollars ($25,000). Maker will pay Holder a $1 closing fee but shall not be charged Interest. This Note is subject to the following terms and conditions. 1. Payment; Prepay |
|
| October 2, 2019 |
As filed with the Securities and Exchange Commission on October 2, 2019 As filed with the Securities and Exchange Commission on October 2, 2019 Registration No. |
|
| October 2, 2019 |
Unsecured Promissory Note dated June 26, 2019, made by the Company in favor of Barry F. Cohen(3) EX-10.19 11 fs12019ex10-19avramed.htm UNSECURED PROMISSORY NOTE DATED JUNE 26, 2019, MADE BY THE COMPANY IN FAVOR OF BARRY F. COHEN Exhibit 10.19 3UNSECURED PROMISSORY NOTE $40,000 June 26, 2019 For value received, (the “Maker”), Avra Medical Robotics, Inc (OTCQB: AVMR) promises to pay to Barry F. Cohen (the “Holder”), the principal sum of Forty Thousand Dollars ($40,000). Maker will pay Holder a |
|
| October 2, 2019 |
Unsecured Promissory Note dated May 8, 2019, made by the Company in favor of Barry F. Cohen(3) Exhibit 10.17 UNSECURED PROMISSORY NOTE $25,000 May 8, 2019 For value received, (the ?Maker?), Avra Medical Robotics, Inc (OTCQB: AVMR) promises to pay to Barry F. Cohen (the ?Holder?), the principal sum of Twenty Five Thousand Dollars ($25,000). Maker will pay Holder a $1 closing fee but shall not be charged Interest. This Note is subject to the following terms and conditions. 1. Payment; Prepaym |
|
| October 2, 2019 |
Unsecured Promissory Note dated July 19, 2019, made by the Company in favor of Barry F. Cohen(3) Exhibit 10.20 UNSECURED PROMISSORY NOTE $50,000 July 19, 2019 For value received, (the ?Maker?), Avra Medical Robotics, Inc (OTCQB: AVMR) promises to pay to Barry F. Cohen (the ?Holder?), the principal sum of Fifty Thousand Dollars ($50,000). Maker will pay Holder a $1 closing fee but shall not be charged Interest. This Note is subject to the following terms and conditions. 1. Payment; Prepayment. |
|
| October 2, 2019 |
Service Agreement between the Company and Dr. Ray Powers(3) EX-10.11 3 fs12019ex10-11avramed.htm SERVICE AGREEMENT BETWEEN THE COMPANY AND DR. RAY POWERS Exhibit 10.11 PRIVATE & CONFIDENTIAL August 1st, 2016 Mr. Ray Powers +1-480 220-8925 [email protected] Dear Ray: This letter will set forth the principal terms of our offer to you of employment with AVRA Medical Robotics, Inc. (“AVRA” or the “Company”). Start Date: August 1, 2016. Position: Chief Operating |
|
| October 2, 2019 |
Unsecured Promissory Note dated August 26, 2019, made by the Company in favor of Barry F. Cohen(3) Exhibit 10.21 UNSECURED PROMISSORY NOTE $100,000 August 26, 2019 For value received, (the ?Maker?), Avra Medical Robotics, Inc (OTCQB: AVMR) promises to pay to Barry F. Cohen (the ?Holder?), the principal sum of One Hundred Thousand Dollars ($100,000). Maker will pay Holder a $1 closing fee but shall not be charged Interest. This Note is subject to the following terms and conditions. 1. Payment; P |
|
| October 2, 2019 |
Service Agreement between the Company and Dr. Nikhil L. Shah*** Exhibit 10.13 PRIVATE & CONFIDENTIAL March 1st, 2018 Dr. Nikhil L. Shah 3456 Habersham RD NW Atlanta, GA 30305-1157 (505) 463-8680 [email protected] Dear Nikhil: This letter will set forth the principal terms of our offer to you of employment with AVRA Medical Robotics, Inc. (?AVRA? or the ?Company?). Start Date: March 1, 2018. Position: Chief Strategy Officer with duties and responsibilities |
|
| October 2, 2019 |
Unsecured Promissory Note dated February 6, 2019, made by the Company in favor of Barry F. Cohen(3) Exhibit 1016 UNSECURED PROMISSORY NOTE $17,500 February 6, 2019 For value received, (the ?Maker?), Avra Medical Robotics, Inc (OTCQB: AVMR) promises to pay to Barry F. |
|
| October 2, 2019 |
Service Agreement between the Company and Dr. Farhan Taghizadeh(3) Exhibit 10.12 PRIVATE & CONFIDENTIAL September 15, 2017 Dr. Farhan Taghizadeh (505) 463-8680 [email protected] Dear Farhan: This letter will set forth the principal terms of our offer to you of employment with AVRA Medical Robotics, Inc. (?AVRA? or the ?Company?). Start Date: September 1, 2017. Position: Chief Medical Officer with duties and responsibilities commonly associated with such posi |
|
| August 7, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant |
|
| July 3, 2019 |
10-K/A 1 f10k2018a1avramedical.htm AMENDMENT NO. 1 TO ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A AMENDMENT NO. 1 TO FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC (Exact name of registr |
|
| July 3, 2019 |
AVRA MEDICAL ROBOTICS, INC. 3259 Progress Drive Suite 112A Orlando, FL 32826 AVRA MEDICAL ROBOTICS, INC. 3259 Progress Drive Suite 112A Orlando, FL 32826 July 3, 2019 Via EDGAR Securities and Exchange Commission Division of Corporation Finance Mail Stop 3030 100 ?F? Street, N.E. Washington, D.C. 20549-3629 Attention: Ms. Jeanne Bennett Mr. Gary Todd Re: AVRA Medical Robotics, Inc. (the ?Company?) Form 10-K for the Fiscal Year Ended December 31, 2018 Filed April 16, 2019 Fi |
|
| May 15, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant |
|
| April 16, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or Other Jurisdiction of (I.R.S. Employe |
|
| March 29, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number: 333-216054 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: December 31, 2018 ? Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on For |
|
| January 31, 2019 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): January 31, 2019 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in charter) Florida (State or other jurisdiction of incorporation) 333-216054 47-3478854 (Commissio |
|
| January 31, 2019 |
3259 Progress Drive, Orlando, FL 32826 EX-99.1 2 s115754ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 January 31, 2019 Dear Shareholder, Over 95% of you have been with the AVRA TEAM and me for more than six years. You have been patient, supportive and well-wishing during these past years. Our most recent investors have been with AVRA for two years now and have supplied important help carrying our Mission to fruition. We have seen AVRA Medical a |
|
| December 7, 2018 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFCTIVE AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in its charter) Florida 3841 47-3478854 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) |
|
| November 13, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of regist |
|
| August 13, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant |
|
| July 27, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): July 24, 2018 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in charter) Florida (State or other jurisdiction of incorporation) 333-216054 47-3478854 (Commission F |
|
| May 17, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant |
|
| May 15, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 SEC File Number: 333-216054 NOTIFICATION OF LATE FILING (Check One): ? Form 10-K ? Form 20-F ? Form 11-K ? Form 10-Q ? Form 10-D ? Form N-SAR ? Form N-CSR For Period Ended: March 31, 2018 ?Transition Report on Form 10-K ? Transition Report on Form 20-F ? Transition Report on Form 11-K ? Transition Report on Form 10 |
|
| March 29, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTIONS 13 OR 15 (d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC (Exact name of registrant as specified in its charter) Florida 47-3478854 (State or Other Jurisdiction of (I.R.S. Employe |
|
| March 16, 2018 |
Conversion Agreement between the Company and A. Christian Schauer(2) Exhibit 10.11 CONVERSION AGREEMENT THIS AGREEMENT, made effective August 1, 2017 (the ?Effective Date?), between AVRA Medical Robotics Inc., a Florida corporation (hereinafter referred to as the ?Company?), and Albert Christian Schauer, residing at 6455 N 39th Street, Augusta, Michigan 49012, USA (hereinafter referred to as the ?Employee?). WHEREAS, the Company wishes to convert payments due to th |
|
| March 16, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): February 23, 2018 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in charter) Florida (State or other jurisdiction of incorporation) 333-216054 47-3478854 (Commissi |
|
| March 16, 2018 |
Conversion Agreement between the Company and Barry F. Cohen(2) EX-10.10 2 s109375ex10-10.htm EXHIBIT 10.10 Exhibit 10.10 CONVERSION AGREEMENT THIS AGREEMENT, made effective July 1, 2017 (the “Effective Date”), between AVRA Medical Robotics, Inc., a Florida corporation (hereinafter referred to as the “Company”), and Barry F. Cohen, residing at 1600 SE 15th Street, #512, Ft. Lauderdale, FL 33316, USA (hereinafter referred to as the “Employee”). WHEREAS, the Com |
|
| February 28, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A AMENDMENT NO. 1 TO FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOT |
|
| November 14, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of regist |
|
| October 12, 2017 |
Unregistered Sales of Equity Securities UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): October 10, 2017 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in charter) Florida (State or other jurisdiction of incorporation) 333-216054 47-3478854 (Commissio |
|
| September 27, 2017 |
EX-99.1 2 s107597ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 AVRA MEDICAL ROBOTICS, INC. UPDATES SHAREHOLDERS AND THE INVESTMENT COMMUNITY WITH RESPECT TO RECENT EVENTS RAISING AVRA’S VISIBILITY IN THE MEDICAL ROBOTICS FIELD Orlando, Florida – September 21-, 2017 – AVRA Medical Robotics, Inc. (“AVRA”), which is planning to enter the field of medical robotics through the development of an intelligent medi |
|
| September 27, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): September 15, 2017 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in charter) Florida (State or other jurisdiction of incorporation) 333-216054 47-3478854 (Commiss |
|
| August 29, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 333-216054 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant |
|
| July 27, 2017 |
AVRA MEDICAL ROBOTICS, INC. 3259 Progress Drive Suite 126 Orlando, FL 32826 AVRA MEDICAL ROBOTICS, INC. 3259 Progress Drive Suite 126 Orlando, FL 32826 July 27, 2017 Via EDGAR Securities and Exchange Commission Division of Corporation Finance Mail Stop 3030 100 ?F? Street, N.E. Washington, D.C. 20549-3629 Attention: Ms. Laurie Abbott Ms. Amanda Ravitz Ms. Julie Sherman Ms. Kate Tillan Re: AVRA Medical Robotics, Inc. (the ?Company?) Registration Statement on Form S-1, as a |
|
| July 26, 2017 |
AVRA MEDICAL ROBOTICS, INC. 3259 Progress Drive Suite 126 Orlando, FL 32826 AVRA MEDICAL ROBOTICS, INC. 3259 Progress Drive Suite 126 Orlando, FL 32826 July 26, 2017 Via EDGAR Securities and Exchange Commission Division of Corporation Finance Mail Stop 3030 100 ?F? Street, N.E. Washington, D.C. 20549-3629 Attention: Ms. Laurie Abbott Ms. Amanda Ravitz Ms. Julie Sherman Ms. Kate Tillan Re: AVRA Medical Robotics, Inc. (the ?Company?) Registration Statement on Form S-1, as a |
|
| July 13, 2017 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 3 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in its charter) Florida 3841 47-3478854 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification |
|
| July 13, 2017 |
AVRA MEDICAL ROBOTICS, INC. 3259 Progress Drive Suite 126 Orlando, FL 32826 AVRA MEDICAL ROBOTICS, INC. 3259 Progress Drive Suite 126 Orlando, FL 32826 July 13, 2017 Via EDGAR Securities and Exchange Commission Division of Corporation Finance Mail Stop 3030 100 ?F? Street, N.E. Washington, D.C. 20549-3629 Attention: Ms. Laurie Abbott Ms. Amanda Ravitz Ms. Julie Sherman Ms. Kate Tillan Re: AVRA Medical Robotics, Inc. Amendment No. 2 to Registration Statement on Form S-1 Fi |
|
| June 20, 2017 |
AVRA MEDICAL ROBOTICS, INC. 3259 Progress Drive Suite 126 Orlando, FL 32826 AVRA MEDICAL ROBOTICS, INC. 3259 Progress Drive Suite 126 Orlando, FL 32826 June 20, 2017 Via EDGAR Securities and Exchange Commission Division of Corporation Finance Mail Stop 3030 100 ?F? Street, N.E. Washington, D.C. 20549-3629 Attention: Ms. Laurie Abbott Ms. Amanda Ravitz Ms. Julie Sherman Ms. Kate Tillan Re: AVRA Medical Robotics, Inc. Amendment No. 1 to Registration Statement on Form S-1 Fi |
|
| June 20, 2017 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in its charter) Florida 3841 47-3478854 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification |
|
| May 11, 2017 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in its charter) Florida 3841 47-3478854 (State or other jurisdiction of (Primary Standard Industrial (I.R.S. Employer incorporation or organization) Classification Code Number) Identification |
|
| May 11, 2017 |
Form of 7.5% Convertible Promissory Note due June 30, 2017(3)* Exhibit 10.9 THIS 7.5% CONVERTIBLE PROMISSORY NOTE (THE ?NOTE?) AND THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE APPLICABLE SECURITIES ACT OF 1933, AS AMENDED (THE ?SECURITIES ACT?) OR UNDER THE SECURITIES LAWS OF ANY STATE. THIS NOTE HAS BEEN ACQUIRED FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TO THE DISTRIBUTION THEREOF. THIS NOTE AND THE SECURITIES ISSUABLE |
|
| May 11, 2017 |
AVRA MEDICAL ROBOTICS, INC. 3259 Progress Drive Suite 126 Orlando, FL 32826 AVRA MEDICAL ROBOTICS, INC. 3259 Progress Drive Suite 126 Orlando, FL 32826 May 11, 2017 Via EDGAR Securities and Exchange Commission Division of Corporation Finance Mail Stop 3030 100 ?F? Street, N.E. Washington, D.C. 20549-3629 Attention: Ms. Laurie Abbott Ms. Amanda Ravitz Ms. Julie Sherman Ms. Kate Tillan Re: AVRA Medical Robotics, Inc. Registration Statement on Form S-1 Filed February 14, 201 |
|
| May 11, 2017 |
Form of Indemnification Agreement(1)* Exhibit 10.8 INDEMNIFICATION AGREEMENT This Indemnification Agreement (this ?Agreement?), dated as of the day of , 201 is made by and between Avra Medical Robotics Inc., a Florida corporation (the ?Company?), , residing at , USA (the ?Indemnitee?). RECITALS A. The Company and the Indemnitee recognize that the present state of the law is too uncertain to provide the Company?s officers and directors |
|
| February 14, 2017 |
SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 AVRA MEDICAL ROBOTICS, INC. (Exact name of registrant as specified in its charter) Florida 3841 47-3478854 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) 3259 Progress |
|
| February 14, 2017 |
EX-10.1 4 s105290ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 AVRA MEDICAL ROBOTICS, INC. 2016 STOCK INCENTIVE PLAN 1. Purposes of the Plan. The purposes of this Plan are to attract and retain the best available personnel, to provide additional incentives to Employees, Directors and Consultants and to promote the success of the Company’s business. 2. Definitions. The following definitions shall apply as u |
|
| February 14, 2017 |
Research Agreement with the University of Central Florida(1) Exhibit 10.2 RESEARCH AGREEMENT Between AVRA Medical Robotics, Inc. And UNIVERSITY OF CENTRAL FLORIDA 12201 Research Parkway, Suite 501, Orlando, FL 32826-3246 This research agreement (“Agreement”) is made and entered into by and between AVRA Medical Robotics, lnc. (“Company”) and The University of Central Florida Board of Trustees (“UCF”), (individually, “Party”, or collectively, “Parties”). The |
|
| February 14, 2017 |
Employment Agreement with Alexandre S. Clug(1)* Exhibit 10.5 EMPLOYMENT AGREEMENT THIS AGREEMENT, made effective August 1, 2016 (the "Effective Date"), between AVRA Medical Robotics Inc., a Florida corporation (hereinafter referred to as the "Company"), and Albert Christian Schauer, residing at 6455 N 39th Street, Augusta, Michigan 49012, USA (hereinafter referred to as the "Employee"). WHEREAS, the Company wishes to engage the services and exp |
|
| February 14, 2017 |
Amended and Restated Articles of Incorporation(1) Exhibit 3.1(i) AMENDED AND RESTATED ARTICLES OF INCORPORATION OF AVRA SURGICAL MICROSYSTEMS, INC. The Articles of Incorporation of AVRA SURGICAL MICROSYSTEMS, INC. (the “Corporation”), originally filed with the Florida Secretary of State on February 4, 2015, are hereby amended and restated in their entirety under the Florida Business Corporation Act (“FCBA”) as follows: ARTICLE I. NAME The name of |
|
| February 14, 2017 |
Form of Director Appointment Agreement(1) Exhibit 10.6 AVRA Medical Robotics, Inc. 3259 Progress Drive, Suite 126, Orlando, FL 32826 NON-EXECUTIVE DIRECTOR LETTER OF APPOINTMENT USA , 201 Dear , I am writing to confirm the terms of your appointment as non-executive director of AVRA Medical Robotics, Inc., a Florida corporation ("the Company"), which will be ratified by the board of directors of the Company (?the Board?) no later than at t |
|
| February 14, 2017 |
Exhibit 3.2 BYLAWS OF AVRA MEDICAL ROBOTICS, INC. ARTICLE I NAME AND OFFICES 1. Name. The name of the Corporation is Avra Medical Robotics, Inc. (the ?Corporation?). 2. Office. The principal office of the Corporation is to be located at such place, either within or without the State of Florida, as the Board of Directors (the ?Board?) shall designate from time to time. Offices may also be kept at s |
|
| February 14, 2017 |
Employment Agreement with Barry F. Cohen(1)* Exhibit 10.3 EMPLOYMENT AGREEMENT THIS AGREEMENT, made effective August 1, 2016 (the "Effective Date"), between AVRA Medical Robotics Inc., a Florida corporation (hereinafter referred to as the "Company"), and Alexandre S. Clug, residing at 262 Fortuna Drive, Palm Beach Gardens, FL 33410, USA (hereinafter referred to as the "Employee"). WHEREAS, the Company wishes to engage the services and expert |
|
| February 14, 2017 |
Employment Agreement with A. Christian Schauer(1)* Exhibit 10.4 EMPLOYMENT AGREEMENT THIS AGREEMENT, made effective July 1, 2016 (the "Effective Date"), between AVRA Medical Robotics Inc., a Florida corporation (hereinafter referred to as the "Company"), and Barry F. Cohen, residing at 1600 SE 15th Street, #512, Ft. Lauderdale, FL 33316, USA (hereinafter referred to as the "Employee"). WHEREAS, the Company wishes to engage the services and experti |
|
| February 14, 2017 |
Exhibit 10.7 August 20, 2016 AVRA MEDICAL ROBOTICS, INC. Code of Business Conduct and Ethics for Employees and Directors Introduction This is the Code of Conduct for AVRA Medical Robotics, Inc. Employees and Directors (the ?Code?). This Code sets out ten important rules that we, as members of the Board of Directors of AVRA Medical Robotics, Inc. (the ?Board?), and as employees, have chosen to guid |
